Bioinductive Patch for Rotator Cuff Tears
Trial Summary
What is the purpose of this trial?
This trial compares standard rotator cuff surgery with and without a special patch that helps the tendon heal. It targets patients who haven't improved with other treatments. The patch is expected to improve healing by encouraging tendon regrowth.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Regeneten Bioinductive Implant for rotator cuff tears?
Research shows that the Regeneten Bioinductive Implant can increase tendon thickness and improve healing in rotator cuff repairs, potentially reducing the chance of the tear happening again. Studies have also shown promising early results in creating a healing response and thickening the injured tendon.12345
Is the Bioinductive Patch for Rotator Cuff Tears safe for humans?
The Bioinductive Patch, also known as the Regeneten Bioinductive Implant, has been used in surgeries to help heal rotator cuff tears. Studies have shown it can increase tendon thickness and support healing, but some patients may experience increased stiffness or need additional surgery. Overall, it is considered safe, but like any medical procedure, there are potential risks.14567
How is the Regeneten Bioinductive Implant treatment different from other treatments for rotator cuff tears?
The Regeneten Bioinductive Implant is unique because it uses a bioinductive patch made from bovine collagen to promote healing and increase tendon thickness, unlike traditional repairs that focus solely on mechanical fixation. This patch helps improve the biology at the repair site by enhancing collagen formation and reducing strain on the tendon, which may lead to better healing outcomes.45789
Research Team
Stephanie J Muh, MD
Principal Investigator
Henry Ford Health
Eligibility Criteria
This trial is for adults over 18 who have medium to massive full-thickness rotator cuff tears, confirmed by imaging, and haven't improved after at least 6 weeks of physical therapy. It's not for those with previous shoulder surgeries (other than diagnostic arthroscopy), active infections, planned open shoulder repairs, acute injuries, small or partial tears, subscapularis tendon involvement, or autoimmune conditions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Patients undergo arthroscopic rotator cuff repair, with the study group receiving an additional bioinductive patch implant
Follow-up
Participants are monitored for rotator cuff repair integrity and other outcomes using ultrasound and PROMs scores
Long-term follow-up
Participants are monitored for additional outcomes such as shoulder strength, range of motion, and complications
Treatment Details
Interventions
- Regeneten Bioinductive Implant (Bioinductive Patch)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Henry Ford Health System
Lead Sponsor
Smith & Nephew, Inc.
Industry Sponsor
Dr. Maria Berkman
Smith & Nephew, Inc.
Chief Medical Officer since 2023
MD from Harvard Medical School
Dr. Deepak Nath
Smith & Nephew, Inc.
Chief Executive Officer since 2022
PhD in Theoretical Mechanics, University of California, Berkeley